Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Dividend Payment Analysis Hennessy Advisors NASDAQ HNNA

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Finance_Assets (2)
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

Hennessy Advisors (NASDAQ: HNNA) will be issuing a dividend payment of $0.14 per share on March 4, 2024, resulting in an annualized dividend yield of 8.33%. Shareholders who owned the stock before the ex-dividend date on February 16, 2024, will receive this payout. This company has a track record of consistent dividend distributions, consistently offering quarterly dividends of $0.14 per share in recent years.

In comparison to its industry counterparts, Hennessy Advisors maintains a moderate position in terms of dividend yield, with OFS Credit Co (NASDAQ: OCCI) leading the pack with an annualized dividend yield of 16.46%.

Investors seeking income are often drawn to companies that provide reliable cash dividends, particularly those that are financially stable and can sustain their dividend payouts over time. It is common for investors to monitor whether a company is increasing or decreasing its dividend payments, along with evaluating its earnings growth, to assess its overall financial well-being.

Hennessy Advisors Inc. (HNNA) Stock Sees Slight Uptick on March 4, 2024 with 0.70% Increase in Value

On March 4, 2024, investors saw a slight uptick in the performance of Hennessy Advisors Inc. (HNNA) stock. The stock opened at $6.74, which was $0.05 higher than its previous close. Throughout the trading day, the price of HNNA shares increased by $0.05, resulting in a 0.70% rise in value.

HNNA Stock Financial Performance Decline in Q1 2024: Revenue and Net Income Down

On March 4, 2024, HNNA stock experienced a decline in its financial performance compared to the previous year and quarter. According to data from CNN Money, the total revenue for the company was reported at $24.02 million for the past year, which is a decrease of 19.03% from the previous year. In the first quarter of 2024, the total revenue was $6.14 million, which remained flat compared to the previous quarter.

Similarly, the net income for HNNA was $4.77 million for the past year, showing a decrease of 22.92% from the previous year. In the first quarter of 2024, the net income was reported at $1.20 million, reflecting a further decrease of 10.51% from the previous quarter.

Furthermore, the earnings per share (EPS) for HNNA were $0.63 for the past year, which is a decrease of 23.38% from the previous year. In the first quarter of 2024, the EPS was reported at $0.16, showing a decrease of 11.14% from the previous quarter.

The decline in HNNA’s financial performance could be attributed to various factors such as changes in market conditions, increased competition, or internal operational challenges. Investors and analysts may closely monitor these financial indicators to assess the company’s overall health and future prospects.

Tags: HNNA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Title Patrick Industries Announces Dividend Payout for Shareholders

CRWD stock news

Analysts Bullish on GitLab Ahead of FourthQuarter Earnings Release

Finance_Capitalistic

Cantor Fitzgerald Analyst Reiterates Overweight Rating on 89bio with 29 Price Target

Recommended

OHI stock news

Bel Fuse Director Sells 56700 Worth of Shares Amid Financial Challenges

2 years ago
I-Mab Stock

NovaBridge Biosciences Unveils Promising Clinical Trial Data and Strategic Rebranding

5 months ago
Nvidia Stock

Nvidia’s Key Supplier Signals Unwavering AI Demand

2 months ago
Silber Stock

Silver’s Perfect Storm: A Market Poised for Breakout

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Trending

SOXX ETF Stock
Commodities

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

by Kennethcix
March 25, 2026
0

The semiconductor industry finds itself navigating a complex landscape where geopolitical developments intersect with tangible supply chain...

Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance
  • Figma Embraces Third-Party AI to Power Its Design Ecosystem

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com